TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $41,588,000 | -15.0% | 626,046 | -0.2% | 0.07% | -2.8% |
| Q2 2021 | $48,943,000 | -17.7% | 627,313 | -0.3% | 0.07% | -18.2% |
| Q1 2021 | $59,504,000 | -22.2% | 629,069 | +0.2% | 0.09% | -29.6% |
| Q4 2020 | $76,516,000 | +83.6% | 627,951 | +31.6% | 0.12% | +62.3% |
| Q3 2020 | $41,671,000 | +35.3% | 477,000 | 0.0% | 0.08% | -1.3% |
| Q2 2020 | $30,810,000 | +51.0% | 477,000 | +4.4% | 0.08% | -10.3% |
| Q1 2020 | $20,410,000 | -8.2% | 457,000 | +28.0% | 0.09% | +4.8% |
| Q4 2019 | $22,238,000 | +6.2% | 357,000 | -35.9% | 0.08% | +12.2% |
| Q3 2019 | $20,943,000 | -7.6% | 557,000 | 0.0% | 0.07% | -17.8% |
| Q2 2019 | $22,670,000 | – | 557,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |